PE20050323A1 - Metodo para la preparacion de mirtazapina enantiomericamente pura - Google Patents
Metodo para la preparacion de mirtazapina enantiomericamente puraInfo
- Publication number
- PE20050323A1 PE20050323A1 PE2004000653A PE2004000653A PE20050323A1 PE 20050323 A1 PE20050323 A1 PE 20050323A1 PE 2004000653 A PE2004000653 A PE 2004000653A PE 2004000653 A PE2004000653 A PE 2004000653A PE 20050323 A1 PE20050323 A1 PE 20050323A1
- Authority
- PE
- Peru
- Prior art keywords
- acid
- preparation
- mirtazapine
- enantiomerically pure
- solvent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A UN METODO PARA LA PREPARACION DE MIRTAZAPINA, 1,2,3,4,10,14b-HEXAHIDRO-2-METIL-PIRAZINO[2,1-a]PIRIDO [2,3-c] [2] BENZAZEPINA, ENANTIOMERICAMENTE PURA, QUE COMPRENDE UN PASO DE CIERRE DEL ANILLO DE UN COMPUESTO DE ACUERDO CON LA FORMULA II, DONDE X ES UN GRUPO SALIENTE. DICHO PASO DE CIERRE DEL ANILLO COMPRENDE EL TRATAMIENTO CON UN ACIDO EN AUSENCIA DE SOLVENTE O UNA COMBINACION ADECUADA DE UN ACIDO Y UN SOLVENTE ORGANICO, CARACTERIZADO PORQUE SE FORMA MIRTAZAPINA CON EXCESO ENANTIOMERICO. TAMBIEN SE REFIERE A QUE DICHO ACIDO PREFERENTEMENTE ES UN ACIDO PROTICO O UN DERIVADO DE ACIDO PROTICO Y EL SOLVENTE ORGANICO ES UN SOLVENTE DE COORDINACION POLAR, PREFERENTEMENTE N-METILPIRROLIDINONA o DIMETILFORMAMIDA (DMF)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03102095 | 2003-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20050323A1 true PE20050323A1 (es) | 2005-05-16 |
Family
ID=34042934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004000653A PE20050323A1 (es) | 2003-07-10 | 2004-07-07 | Metodo para la preparacion de mirtazapina enantiomericamente pura |
Country Status (36)
Country | Link |
---|---|
US (2) | US8058436B2 (es) |
EP (1) | EP1656365B1 (es) |
JP (1) | JP4668184B2 (es) |
KR (1) | KR20060056315A (es) |
CN (1) | CN100558722C (es) |
AR (1) | AR046494A1 (es) |
AT (1) | ATE433965T1 (es) |
AU (1) | AU2004255874B2 (es) |
BR (1) | BRPI0412447A (es) |
CA (1) | CA2531165C (es) |
CO (1) | CO5640123A2 (es) |
CY (1) | CY1109327T1 (es) |
DE (1) | DE602004021605D1 (es) |
DK (1) | DK1656365T3 (es) |
EC (1) | ECSP066271A (es) |
ES (1) | ES2327123T3 (es) |
HK (1) | HK1086841A1 (es) |
HR (1) | HRP20051019A2 (es) |
IL (1) | IL172549A0 (es) |
IS (1) | IS2674B (es) |
LT (1) | LT5382B (es) |
LV (1) | LV13441B (es) |
MX (1) | MXPA06000325A (es) |
NO (1) | NO20056175L (es) |
NZ (1) | NZ544360A (es) |
PE (1) | PE20050323A1 (es) |
PL (1) | PL1656365T3 (es) |
PT (1) | PT1656365E (es) |
RS (1) | RS20050972A (es) |
RU (1) | RU2352566C2 (es) |
SG (1) | SG144914A1 (es) |
SI (1) | SI1656365T1 (es) |
TW (1) | TWI335915B (es) |
UA (1) | UA83666C2 (es) |
WO (1) | WO2005005410A1 (es) |
ZA (1) | ZA200600019B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5080050B2 (ja) * | 2005-09-26 | 2012-11-21 | 住友化学株式会社 | 光学活性なピペラジン化合物の製造方法 |
WO2007035003A1 (ja) * | 2005-09-26 | 2007-03-29 | Sumitomo Chemical Company, Limited | 光学活性なピペラジン化合物の製造方法 |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
TW200815370A (en) * | 2006-06-16 | 2008-04-01 | Organon Nv | Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine |
US8273883B2 (en) | 2007-02-09 | 2012-09-25 | Kaneka Corporation | Method for producing optically active 2-arylpiperazine derivative |
JP5192707B2 (ja) * | 2007-03-22 | 2013-05-08 | 住友化学株式会社 | ミルタザピンの製造方法 |
CA2684021A1 (en) * | 2007-04-11 | 2008-10-23 | N.V. Organon | A method for the preparation of an enantiomer of a tetracyclic benzazepine |
US7994314B2 (en) | 2007-04-11 | 2011-08-09 | N.V. Organon | Method for the preparation of an enantiomerically pure benzazepine |
KR101485418B1 (ko) * | 2013-05-29 | 2015-01-26 | 주식회사 메디켐코리아 | 고순도 미르타자핀의 제조방법 |
HUE055000T2 (hu) | 2015-02-27 | 2021-10-28 | Dechra Ltd | Étvágy stimulálása, tömegvesztés kézbentartása és anorexia kezelése kutyák és macskák esetében |
KR102540021B1 (ko) * | 2020-12-02 | 2023-06-07 | (주)유케이케미팜 | 대량 생산에 적합한 미르타자핀의 제조방법 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959470A (en) * | 1972-11-28 | 1976-05-25 | Mikhail Davidovich Mashkovsky | Psychotropic medicinal preparation |
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
IE903557A1 (en) * | 1989-10-05 | 1991-04-10 | Sankyo Co | Novel tetracyclic compounds having anti-allergic and¹anti-asthmatic activities, their preparation and use |
JPH11222407A (ja) * | 1997-11-14 | 1999-08-17 | Sankyo Co Ltd | 新規殺菌剤 |
PL192272B1 (pl) | 1997-11-14 | 2006-09-29 | Akzo Nobel Nv | Zastosowanie mirtazapiny |
US20030069417A1 (en) * | 1999-04-19 | 2003-04-10 | Claude Singer | Novel synthesis and crystallization of piperazine ring-containing compounds |
WO2000062782A1 (en) | 1999-04-19 | 2000-10-26 | Teva Pharmaceutical Industries Ltd. | Novel synthesis and crystallization of piperazine ring-containing compounds |
US6068695A (en) * | 1999-07-13 | 2000-05-30 | Bayer Corporation | Process for the continuous preparation of quinacridones |
AU6476300A (en) | 1999-09-30 | 2001-05-10 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a piperazine derivative |
WO2001042239A1 (fr) | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
ATE317261T1 (de) | 2000-02-11 | 2006-02-15 | Akzo Nobel Nv | Verwendung von mirtazapin zur behandlung von schlafstörungen |
JP2001342188A (ja) * | 2000-03-27 | 2001-12-11 | Takeda Chem Ind Ltd | 縮合ピラゾール誘導体、その製造法および用途 |
TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
-
2004
- 2004-05-07 UA UAA200600274A patent/UA83666C2/ru unknown
- 2004-06-28 TW TW093118845A patent/TWI335915B/zh not_active IP Right Cessation
- 2004-07-05 US US10/564,193 patent/US8058436B2/en not_active Expired - Fee Related
- 2004-07-05 NZ NZ544360A patent/NZ544360A/en not_active IP Right Cessation
- 2004-07-05 BR BRPI0412447-2A patent/BRPI0412447A/pt not_active IP Right Cessation
- 2004-07-05 PT PT04741958T patent/PT1656365E/pt unknown
- 2004-07-05 ES ES04741958T patent/ES2327123T3/es not_active Expired - Lifetime
- 2004-07-05 JP JP2006518216A patent/JP4668184B2/ja not_active Expired - Lifetime
- 2004-07-05 KR KR1020067000511A patent/KR20060056315A/ko active IP Right Grant
- 2004-07-05 MX MXPA06000325A patent/MXPA06000325A/es active IP Right Grant
- 2004-07-05 AU AU2004255874A patent/AU2004255874B2/en not_active Expired
- 2004-07-05 CA CA2531165A patent/CA2531165C/en not_active Expired - Fee Related
- 2004-07-05 AT AT04741958T patent/ATE433965T1/de active
- 2004-07-05 EP EP04741958A patent/EP1656365B1/en not_active Expired - Lifetime
- 2004-07-05 RS YUP-2005/0972A patent/RS20050972A/sr unknown
- 2004-07-05 CN CNB2004800194891A patent/CN100558722C/zh not_active Expired - Lifetime
- 2004-07-05 WO PCT/EP2004/051357 patent/WO2005005410A1/en active IP Right Grant
- 2004-07-05 SG SG200805127-8A patent/SG144914A1/en unknown
- 2004-07-05 PL PL04741958T patent/PL1656365T3/pl unknown
- 2004-07-05 RU RU2006103992/04A patent/RU2352566C2/ru not_active IP Right Cessation
- 2004-07-05 SI SI200431183T patent/SI1656365T1/sl unknown
- 2004-07-05 DE DE602004021605T patent/DE602004021605D1/de not_active Expired - Lifetime
- 2004-07-05 DK DK04741958T patent/DK1656365T3/da active
- 2004-07-07 PE PE2004000653A patent/PE20050323A1/es not_active Application Discontinuation
- 2004-07-08 AR ARP040102412A patent/AR046494A1/es not_active Application Discontinuation
-
2005
- 2005-12-12 LT LT2005107A patent/LT5382B/lt not_active IP Right Cessation
- 2005-12-13 IL IL172549A patent/IL172549A0/en not_active IP Right Cessation
- 2005-12-15 IS IS8184A patent/IS2674B/is unknown
- 2005-12-22 HR HR20051019A patent/HRP20051019A2/xx not_active Application Discontinuation
- 2005-12-23 NO NO20056175A patent/NO20056175L/no not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600019A patent/ZA200600019B/en unknown
- 2006-01-09 EC EC2006006271A patent/ECSP066271A/es unknown
- 2006-01-10 CO CO06001617A patent/CO5640123A2/es not_active Application Discontinuation
- 2006-02-10 LV LVP-06-21A patent/LV13441B/en unknown
- 2006-08-17 HK HK06109133.3A patent/HK1086841A1/xx not_active IP Right Cessation
-
2008
- 2008-07-02 US US12/667,969 patent/US20100179319A1/en not_active Abandoned
-
2009
- 2009-08-25 CY CY20091100894T patent/CY1109327T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20050323A1 (es) | Metodo para la preparacion de mirtazapina enantiomericamente pura | |
PE20091383A1 (es) | DERIVADOS DE IMIDAZO-[1,2-a]PIRIDINA COMO INHIBIDORES DE ALK-5 Y ALK-4 | |
ATE417051T1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
PE20120172A1 (es) | Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide | |
ES2422204T3 (es) | Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS) | |
DK1222173T3 (da) | Fremgangsmåde til fremstilling af 4-trifluormethylsulphinylpyrazolderivat | |
CO6220952A2 (es) | Nuevos derivados de 3-([1,2,4]triazolo[4,3-a]piridin-7-il)benzamida | |
TW200722422A (en) | Heterocyclic compound and organic electroluminescent device using the same | |
PL1740584T3 (pl) | Skondensowana pochodna chinoliny i jej zastosowanie | |
WO2011038185A3 (en) | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | |
EA200901034A1 (ru) | 6-БЕНЗИЛ-2,3,4,7-ТЕТРАГИДРОИНДОЛО [2,3-c]ХИНОЛИНЫ, ПРИМЕНИМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФДЭ5 (ФОСФОДИЭСТЕРАЗЫ 5) | |
CO6220973A2 (es) | Nuevos compuestos triciclicos sustituidos que comprenden 3 a 5 atomos de nitrogeno, derivados de un sistema saturado de 1, 3-diazepina, su preparacion y su utilizacion como medicamentos antibacterianos | |
EP3301097A3 (en) | [1]benzothieno[3',2':4,5]imidazo[1,2-a]pyridine derivatives and related compounds for use in organic light-emitting devices (oleds) | |
UA101018C2 (ru) | Пирролопиримидинкарбоксамиды | |
ATE297931T1 (de) | Tricyclische imidazopyridine | |
CO5611125A2 (es) | Derivados de azetidina como antagonistas del receptor ccr-3 | |
CR7249A (es) | Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo | |
UY27413A1 (es) | Agonistas de la oxitocina | |
DE60006857D1 (de) | Verfahren zur herstellung von pyridinmethanol-verbindungen | |
RS20070095A (en) | Alkyliden-tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents | |
DK1501838T3 (da) | Fremgangsmåde til fremstilling af clopidogrel | |
ATE279191T1 (de) | Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel | |
ATE514702T1 (de) | Verfahren zur herstellung von clopidogrel und dabei verwendete zwischenprodukte | |
CY1107157T1 (el) | Παραγωγα 4-οξο-4,6,7,8-τετραϋδροπυρρολο 1,2-a πυραζινο-6-καρβοξαμιδων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν | |
TW200641000A (en) | Method for producing aromatic polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |